IL126759A0 - Method for treating inflammation - Google Patents

Method for treating inflammation

Info

Publication number
IL126759A0
IL126759A0 IL12675997A IL12675997A IL126759A0 IL 126759 A0 IL126759 A0 IL 126759A0 IL 12675997 A IL12675997 A IL 12675997A IL 12675997 A IL12675997 A IL 12675997A IL 126759 A0 IL126759 A0 IL 126759A0
Authority
IL
Israel
Prior art keywords
treating inflammation
inflammation
treating
Prior art date
Application number
IL12675997A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL126759A0 publication Critical patent/IL126759A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL12675997A 1996-05-03 1997-04-29 Method for treating inflammation IL126759A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/642,816 US5753218A (en) 1996-05-03 1996-05-03 Method for treating inflammation
PCT/US1997/006802 WO1997041882A1 (en) 1996-05-03 1997-04-29 Method for treating inflammation

Publications (1)

Publication Number Publication Date
IL126759A0 true IL126759A0 (en) 1999-08-17

Family

ID=24578143

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12675997A IL126759A0 (en) 1996-05-03 1997-04-29 Method for treating inflammation

Country Status (15)

Country Link
US (1) US5753218A (es)
EP (1) EP0906118A1 (es)
JP (1) JP2000509715A (es)
KR (1) KR20000010706A (es)
AR (1) AR006932A1 (es)
AU (1) AU718857B2 (es)
BR (1) BR9708908A (es)
CA (1) CA2253312A1 (es)
HU (1) HUP9903144A3 (es)
ID (1) ID17194A (es)
IL (1) IL126759A0 (es)
NZ (1) NZ332464A (es)
PE (1) PE64498A1 (es)
WO (1) WO1997041882A1 (es)
ZA (1) ZA973707B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US5800268A (en) 1995-10-20 1998-09-01 Molnick; Melvin Method of participating in a live casino game from a remote location
US7067144B2 (en) * 1998-10-20 2006-06-27 Omeros Corporation Compositions and methods for systemic inhibition of cartilage degradation
MXPA01010480A (es) * 1999-04-13 2002-03-27 Schering Corp Usos novedosos de la proteina 0x2 de mamifero y reactivos relacionados.
US6544504B1 (en) 1999-07-28 2003-04-08 Schering Corporation Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
WO2001008696A2 (en) * 1999-07-28 2001-02-08 Schering Corporation Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
WO2001008717A1 (en) * 1999-08-03 2001-02-08 Smith & Nephew, Inc. Controlled release implantable devices
CA2431206C (en) * 2000-12-08 2009-09-01 Takeda Chemical Industries, Ltd. Combination drugs containing anti-sepsis cycloalkene compound
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2003030720A2 (en) * 2001-10-09 2003-04-17 The Children's Hospital Of Philadelphia Materials and methods for preventing or reducing scar formation
WO2003045322A2 (en) * 2001-11-28 2003-06-05 Schering Corporation Method for treating and preventing pancreatitis
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9511076B2 (en) * 2008-05-30 2016-12-06 Clarion Research Group Formulations and methods for recovery from dental surgery
US20120195938A1 (en) * 2007-05-30 2012-08-02 James Louis Rutkowski Formulations and methods for recovery from dental surgery
US20140294922A1 (en) * 2010-12-22 2014-10-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound with antibacterial activity
CA2928526A1 (en) 2013-11-01 2015-05-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
KR102624174B1 (ko) * 2020-09-18 2024-01-23 주식회사 아미코젠파마 수가용화된 담즙산을 포함하는 패혈증, 급성 폐손상 질환, 또는 급성 호흡곤란증후군의 예방 또는 치료용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US5077284A (en) * 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
EP0502080A4 (en) * 1989-11-21 1993-02-10 The University Of Melbourne Anti-inflammatory compositions and methods
US5300292A (en) * 1991-05-03 1994-04-05 The Regents Of The University Of California Composition and method for treating inflammation
ES2138976T3 (es) * 1991-08-06 2000-02-01 Schering Corp Uso de analogos o antagonistas de interleucina-10 para tratar la toxicidad inducida por endotoxinas o superantigenos.
US5368854A (en) * 1992-08-20 1994-11-29 Schering Corporation Use of IL-10 to treat inflammatory bowel disease
US5601815A (en) * 1992-08-21 1997-02-11 Schering Corp IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
CA2228620A1 (en) * 1995-08-07 1997-02-20 John E. Oakes Treatment of ocular inflammatory conditions with interleukin-10

Also Published As

Publication number Publication date
CA2253312A1 (en) 1997-11-13
HUP9903144A2 (hu) 2000-03-28
HUP9903144A3 (en) 2000-11-28
BR9708908A (pt) 1999-08-03
US5753218A (en) 1998-05-19
AU2808997A (en) 1997-11-26
NZ332464A (en) 2000-07-28
ZA973707B (en) 1997-10-29
JP2000509715A (ja) 2000-08-02
PE64498A1 (es) 1998-10-29
KR20000010706A (ko) 2000-02-25
ID17194A (id) 1997-12-11
AR006932A1 (es) 1999-09-29
EP0906118A1 (en) 1999-04-07
WO1997041882A1 (en) 1997-11-13
AU718857B2 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
IL126203A0 (en) Method for treating pain
EP0906104A4 (en) PAIN TREATMENT PROCESS
AU3813397A (en) Apparatus for treating chondromalicia
EP0792371A4 (en) COMBINED ACNE TREATMENT PROCESS
SG50018A1 (en) Method for developing treatment
IL126759A0 (en) Method for treating inflammation
IL129742A (en) Method for treating diseased plants
IL126064A0 (en) Method for treating pain
GB9605828D0 (en) Treatment method
PL328964A1 (en) Acne treating method
IL126063A0 (en) Method for treating migraine pain
GB9605709D0 (en) Method
EP0786999A4 (en) COMBINED ACNE TREATMENT PROCESS
ZA971899B (en) Method for treating insomnia
AU3740697A (en) Method for treating excessive aggression
GB9605482D0 (en) Method
ZA979453B (en) Oncostatin M for treating inflammation
AU2198997A (en) Method for treating insomnia
GB9605152D0 (en) Method of treating inflammation
IL119272A0 (en) Method for treating acne
GB9606731D0 (en) Method for treating insomnia
GB9606620D0 (en) Method for treating excessive aggression
GB9600610D0 (en) Treatment method
GB9614742D0 (en) Treatment method
GB9614743D0 (en) Treatment method